Singapore Feature Highlights Founder’s Roots and Future Expansion into Asia

Brisbane, Australia – January 24, 2026 – Dr. Clarissa Yates, Ph.D., Founder and CEO of Ketim Technologies, has been featured in Singapore, reflecting on her heritage and the company’s future plans to expand its postpartum depression risk prediction platform into the region.

Born with Eurasian and Chinese heritage, Dr. Yates spent her early years in Singapore before relocating to Australia nearly two decades ago. The feature explores how her multicultural upbringing and non-traditional path into science and entrepreneurship shaped her approach to innovation in maternal mental health.

The interview also highlights Ketim’s long-term vision to introduce its predictive blood-based diagnostic for postpartum depression into Singapore and broader Asian markets, where conversations around maternal mental health continue to evolve.

“Bringing Ketim’s work back to Singapore feels both personal and purposeful,” said Dr. Yates. “Precision medicine must reflect cultural diversity and real-world healthcare systems if it is to make meaningful impact.”

The feature underscores the importance of representation in STEM and the role of diverse leadership in shaping global health innovation.